Oxford Biomedica Stock Price, News & Analysis
Company Description
Oxford Biomedica (OTC Link: OXBDF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $978.1M.
OXBDF stock has gained 87.1% over the past year. Shares last traded at $8.00.
This page provides a comprehensive overview of OXBDF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Oxford Biomedica (OXBDF) stock last traded at $8.00, up 3.09% from the previous close. Over the past 12 months, the stock has gained 87.1%. At a market capitalization of $978.1M, OXBDF is classified as a small-cap stock with approximately 121.0M shares outstanding.
Latest News
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Oxford Biomedica (OXBDF) currently stands at 62.2 thousand shares, up 8.4% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has decreased by 80.3%. This relatively low short interest suggests limited bearish sentiment. The 6.8 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Oxford Biomedica (OXBDF) currently stands at 6.8 days, down 96% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has decreased 99.3% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 3.2 to 1000.0 days.
OXBDF Company Profile & Sector Positioning
Oxford Biomedica (OXBDF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing OXBDF often look at related companies in the same sector, including Pharming Group (PHGUF), Nxera Pharma (SOLTF), Pharma Mar Sa (PHMMF), Genus Plc (GENSY), and Sanbio (SNBOY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OXBDF's relative position within its industry.